SCHEMBL5654826

SCHEMBL5654826

IC1CNCC(c2ccccn2)NC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
MAPT P10636 2/20 0.38
KMT2A Q03164 1/20 0.38
DDB1 Q16531 1/20 0.35
CRBN Q96SW2 1/20 0.35
PARP16 Q8N5Y8 2/20 0.33
PARP3 Q9Y6F1 2/20 0.33
NISCH Q9Y2I1 1/20 0.33
CHRNB2 P17787 1/20 0.33
CHRNB4 P30926 1/20 0.33
CHRNA3 P32297 1/20 0.33
CHRNA7 P36544 1/20 0.33
CHRNA4 P43681 1/20 0.33
KDM4E B2RXH2 4/20 0.33
HSD17B10 Q99714 2/20 0.33
GFER P55789 1/20 0.33
LMNA P02545 1/20 0.32
CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28743073 0.82 DDB1 (0.39) ALDH1A1NPC1RAB9AMAPTKMT2A
SCHEMBL5655543 0.81 ALDH1A1 (0.35) ALDH1A1NPC1RAB9AMAPTKMT2A
SCHEMBL987383 0.78 DDB1 (0.37) ALDH1A1NPC1RAB9AMAPTKMT2A
SCHEMBL20993216 0.78 DDB1 (0.37) ALDH1A1NPC1RAB9AMAPTKMT2A
SCHEMBL20993362 0.78 DDB1 (0.37) ALDH1A1NPC1RAB9AMAPTKMT2A
Hydrochloric Acid SCHEMBL6965524 0.77 DDB1 (0.36) ALDH1A1NPC1RAB9AMAPTKMT2A
SCHEMBL5656692 0.74 DDB1 (0.33) ALDH1A1NPC1RAB9AMAPTKMT2A
SCHEMBL5658706 0.74 DDB1 (0.33) ALDH1A1NPC1RAB9AMAPTKMT2A
SCHEMBL27582745 0.73 PARP16 (0.37) ALDH1A1NPC1RAB9AMAPTKMT2A
SCHEMBL7897281 0.71 CHRNB4 (0.45) ALDH1A1NPC1RAB9AMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7282494-B2 Heteroaryl diazacycloalkanes, their preparation and use NEUROSEARCH A/S (DK) 2007-10-16 US claimed
US-20060100192-A1 Heteroaryl diazacycloalkanes, their preparation and use DANPET AB (SE) 2006-05-11 US claimed
US-20020045618-A1 Heteroaryl diazacycloalkanes, their preparation and use NEUROSEARCH A/S (DK) 2002-04-18 US claimed
US-7282494-B2 Heteroaryl diazacycloalkanes, their preparation and use NEUROSEARCH A/S (DK) 2007-10-16 US disclosed
US-7064118-B2 Heteroaryl diazacycloalkanes, their preparation and use NEUROSEARCH A/S (DK) 2006-06-20 US disclosed
US-20060100192-A1 Heteroaryl diazacycloalkanes, their preparation and use DANPET AB (SE) 2006-05-11 US disclosed
US-20020045618-A1 Heteroaryl diazacycloalkanes, their preparation and use NEUROSEARCH A/S (DK) 2002-04-18 US disclosed
EP-1175416-A1 HETEROARYL DIAZACYCLOALKANES, THEIR PREPARATION AND USE NEUROSEARCH A/S (DK) 2002-01-30 EP disclosed
WO-2000064885-A1 HETEROARYL DIAZACYCLOALKANES, THEIR PREPARATION AND USE NEUROSEARCH A/S (DK) 2000-11-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020045618-A1 Heteroaryl diazacycloalkanes, their preparation and use CHRNA5, CHRNA7, CHRNA3 ALDH1A1 1310/4885NPC1 2276/4885RAB9A 2946/4885
US-20060100192-A1 Heteroaryl diazacycloalkanes, their preparation and use CHRNA5, CHRNA7, CHRNA3 ALDH1A1 1089/4885NPC1 2249/4885RAB9A 3013/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.